Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Diös divests properties for SEK 788 million

Diös Fastigheter divests four properties in Skellefteå with a lettable area of 43,000 square meters, containing primarily retail. The underlying property value is at the same level as the book value. The buyer is Nordvestor Fastigheter and transfer of ownership will take place during January, 2024. The annual rental value for the diverted properties amounts to circa SEK 69 million and the economic occupancy rate amounts to 93 percent. The majority of the properties contain retail, and the largest tenants are Åhléns, ICA and Clas Ohlson. The transaction takes place in a company

Wetteri Plc’s financial reporting and Annual General Meeting in 2024

Wetteri Plc Stock exchange release 21st December 2023 at 14.00 EETWetteri Plc will publish its financial reports in 2024 as follows:  ·14th March 2024: Financial statements bulletin for the 2023 financial year  ·18th April 2024: Annual report and financial statements for the 2023 financial year  ·30th May 2024: Interim report for January–March 2024  ·28th August 2024: Interim report for January–June 2024  ·21st November 2024: Interim report for January–September 2024  Wetteri Plc’s Annual General Meeting is scheduled to be held on 22nd May 2024. The

Jari Vähäpesola appointed as an adviser to Spinnova’s Board of Directors

SPINNOVA PLC, PRESS RELEASE, 21 DECEMBER 2023 AT 14:00 P.M. EET   Jari Vähäpesola appointed as an adviser to Spinnova’s Board of Directors   Spinnova’s Board of Directors has appointed board professional Jari Vähäpesola as an adviser to the Board effective as of December 2023. Jari has had an over 36-year successful career at Valmet heading various business lines. Most recently he acted as Business Line President, Paper and was a member of the Executive Team. He has a M.Sc. degree in mechanical engineering.   Jari will support the Board of Directors in strategic matters

Change in NYAB's Executive Management Team

NYAB PlcCOMPANY ANNOUNCEMENT21 December 2023 at 14:00Change in NYAB’s Executive Management Team Minna Koistinen, Chief Communications & Marketing Officer at NYAB, has announced that she will not continue working for the Company. She has been a member of NYAB’s Executive Management Team since May 2022, and her responsibilities in the Executive Management Team will be assumed by Erik Petersen, Vice President of Corporate Affairs. “Minna has been an essential part of NYAB’s recent development, including strengthening our communications and the NYAB brand. I thank Minna for her

Polymer Factory Sweden AB releases SpheriCal® calibrants for ESI-MS

Fulfilling the Company’s goal of expanding the range of applications for its calibration technology SpheriCal®, the Company has now commercially released calibrants for Electrospray Ionization Mass Spectrometry (ESI-MS). The concept of this new technology was introduced to the market during the 71st ASMS Conference on Mass Spectrometry and Allied Topics (ASMS) this summer and prototypes were released for beta testing earlier this fall. Currently, the Company has calibrants for MALDI-ToF MS commercially available, whereas the goal of the expansion of the SpheriCal® platform is to increase

BioStock: Arcede Pharma appoints acting CEO

Arcede Pharma is in full swing with the preparations for clinical studies with drug candidate RCD405. CEO Mia Lundblad has announced that she will leave her position for a more research-oriented role outside the company. Lundblad will continue as CEO until the beginning of February, when the company’s CFO Erik Magnusson will take over as acting CEO.Read the full article at biostock.se : https://www.biostock.se/en/2023/12/arcede-pharma-appoints-acting-ceo/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

BioStock: Saniona’s CEO shares 2024 business development roadmap

Saniona is focusing on partnering and investing the proceeds from such partnerships to build shareholder value. The goal is long-term success and being less reliant on conventional financing routes. In an interview with BioStock, Saniona’s CEO Thomas Feldthus talks about this in more detail. We also learn more about the new focus on epilepsy treatment and the potential share issue of 140 million SEK in January.Read the full interview with Thomas Feldthus at biostock.se: https://www.biostock.se/en/2023/12/sanionas-ceo-shares-2024-business-development-roadmap/ This is a press release

Massive demand for cooling needed for new industry

One of the biggest waves of industrialisation ever is washing over Sundsvall. Liquid Wind is going to produce e-methanol for shipping, a process that needs enormous amounts of cooling. FVB is responsible for the cooling process, which will be sold by Sundsvall Energi.[Illustration Sundsvall Energi Korstaverket]Liquid Wind is to produce e-methanol for shipping. The process will need enormous amounts of cooling, which will be drawn from the sea near the plant. Illustration: Sundsvall Energi. Liquid Wind’s business concept is to develop ‘electro fuels’ based on hydrogen to meet the shipping

Tectonic Gold Financial Report for the Year Ended 30 June 2023

Tectonic Gold PLC Company Registration No. 05173250 Annual Report and Financial Statements for the year ended 30 June 2023 CONTENTS   Page   3 Company information  4 Chairman’s Report 5                            Chief Executive Officer’s Report 6 Strategic Report 8 Directors’ Report 13 Corporate Governance Statement 17 Report of the independent auditor 23 Consolidated Statement of Profit or Loss and Other Comprehensive Income 24 Statements of Financial Position 25 Consolidated Statement of Changes in Equity 26 Company Statement of Changes

Billerud keeps leading position in sustainability index for 2023

Billerud – including Billerud North America - retains its position as one of the world’s most sustainable companies in its industry sector. This year’s results from the globally recognized Dow Jones Sustainability Indices show that Billerud continues to be one of the leading companies in the Containers & Packaging category.The Dow Jones Sustainability Indices is based on the S&P Global Corporate Sustainability Assessment (CSA), which is a comprehensive annual evaluation of corporate sustainability efforts and performance. The Dow Jones Sustainability World Index includes the top ten percent

BioStock: Evaxion unveils refined business strategy

With a newly appointed CEO, Evaxion Biotech is putting more focus on execution and value realisation through partnerships involving its AI-Immunology platform. BioStock spoke with Evaxion’s CEO Christian Kanstrup about the steps already taken to implement this new strategy and what we can expect from Evaxion in 2024.Read the interview with Christian Kanstrup at biostock.se: Evaxion unveils refined business strategy - BioStock This is a press release from BioStock - Connecting Innovation & Capital. https://

Final Liquidation Distribution

TRIAN INVESTORS 1 LIMITED (IN VOLUNTARY LIQUIDATION)   FINAL LIQUIDATION DISTRIBUTION At an extraordinary general meeting of Trian Investors 1 Limited (in voluntary liquidation) (the “Company”) held on 26 April 2023, shareholders passed resolutions to wind up the Company and Joint Liquidators (the “Liquidators”) were appointed. In accordance with the Circular dated 24 March 2023, the Liquidators announce their intention to make a final liquidation distribution to the Ordinary shareholders (the “Final Distribution”) of: GBP 0.08133 per Ordinary share in issue The Final

NOBA Holding AB (publ)’s subsidiary NOBA Bank Group AB (publ) has successfully issued subordinated Tier 2 bonds

NOBA Holding AB (publ)’s indirect subsidiary NOBA Bank Group AB (publ) (“NOBA”) has today announced that NOBA has successfully issued subordinated Tier 2 bonds of EUR 40,000,000 in a private placement to an investor. The bonds have a 10.25-year tenor with a possible first call after five years and carries an interest of EURIBOR 3 months + 7.00%. The bonds will be listed on Nasdaq Stockholm. Settlement date will be 18 January 2024. The bonds were issued under NOBA’s existing MTN programme which has a total framework of SEK 5 billion. Nordea acted as sole lead manager & structuring

NOBA Bank Group AB (publ) has successfully issued subordinated Tier 2 bonds

NOBA Bank Group AB (publ) (”NOBA”) has successfully issued subordinated Tier 2 bonds of EUR 40,000,000 in a private placement to an investor. The bonds have a 10.25-year tenor with a possible first call after five years and carries an interest of EURIBOR 3 months + 7.00%. The bonds will be listed on Nasdaq Stockholm. Settlement date will be 18 January 2024. The bonds were issued under NOBA’s existing MTN programme which has a total framework of SEK 5 billion. Nordea acted as sole lead manager & structuring advisor in the transaction. For further information, please contact:

Yanfeng and TactoTek partner to enhance future vehicle interior applications

Yanfeng, a leading global automotive supplier, and TactoTek, a pioneer and leader in smart surface technologies, will collaborate on the development of highly integrated Human Machine Interface (HMI) solutions for future Smart Cabin applications. The goal of this partnership is to combine advanced lighting, user interfaces, as well as various decorative trim with a deeply integrated product approach that enables exceptional design flexibility.Yanfeng has made the strategic decision to integrate TactoTek's Injection Molded Structural Electronics (IMSE) portfolio as a technological layer in

Immedica intends to re-submit the BLA seeking approval of Loargys® (pegzilarginase) for treatment of arginase 1 deficiency (ARG1-D) in the US

Stockholm, December 21, 2023: Immedica today announces its intention to re-submit the biologics license application (BLA) seeking approval of Loargys® (pegzilarginase) for the treatment of arginase 1 deficiency (ARG1-D) in the US during 2024. The decision was taken following the recent approval of Loargys by the European Commission on December 15 and after a dialogue with the FDA. About Loargys®Loargys (pegzilarginase) is a novel recombinant human enzyme and has been shown to rapidly and sustainably lower levels of the amino acid arginine and its toxic metabolites in plasma

Spinomenal Share Festive Joy with Holidays Joker Xmas Slot

Leading iGaming content provider Spinomenal has launched Holidays Joker Xmas in celebration of this magical time of year. This Christmas-inspired title delivers joy and excitement in equal measure thanks to its captivating gameplay.Players can trigger the Free Spins game by landing three or more Scattered Free Spins symbols. The game awards 10, 25, or 50 Free Spins for landing three, four, or five Scatters, respectively. The game’s medium symbols, including presents, baubles, stockings, and gingerbread men, add to the merriment. Lifting the excitement further is the Wild Joker symbol,

BioStock: FDA CAR T investigation does not affect Elicera

The FDA is investigating safety risks in patients receiving CAR T-cell immunotherapies after reports of T-cell malignancies, including CAR-positive lymphoma. All six approved CAR T drugs are being placed under increased scrutiny by the American regulators. We spoke with Jamal El-Mosleh, CEO of cell- and gene therapy company Elicera Therapeutics, to see how this might affect a CAR T developer like Elicera.Read the interview with Jamal El-Mosleh at biostock.se: FDA CAR T investigation does not affect Elicera - BioStock 

DS Smith uses biobased adhesive in corrugated board packaging

DS Smith, a manufacturer of corrugated board packaging, has switched to using biobased adhesive in its refining process. The transition to the new product went smoothly, and the company has been using Kiilto’s Pack Eco adhesive for several years now. With this change, both DS Smith and Kiilto are advancing their environmental goals.Sustainability is an integral part of the circular economy business model of the corrugated board packaging manufacturer DS Smith . Kiilto also aims to be an environmental pioneer within its industry. The ambitious goals of the two

BioStock: BioInvent’s CEO: “This year we made unprecedented progress”

2023 has undoubtedly been one of the most successful for BioInvent, if not the most successful. The company’s cancer treatment pipeline currently includes five drug candidates progressing through six clinical trials – and progress has been announced in all programmes during the year. However, in the current tough market dynamics for biotech, like many other companies, BioInvent is valued under cash. BioStock contacted CEO Martin Welschof to talk about the progress during 2023 and to learn about his expectations for next year.Read the full interview with Martin Welschof at biostock.se:

Voi e-scooters will shut down for New Year’s Eve

Voi e-scooter. Credit: Voi UK, 21 December 2023: Rental e-scooter company, Voi, is advising riders to plan their journeys this New Year’s Eve as, with the exception of London, e-scooters will be temporarily unavailable after 9pm to discourage drinking and scooting. The safety measure, agreed with local authorities in the areas where Voi operates outside of London, will see e-scooters temporarily disabled from 9pm on 31 December 2023 until 8am on 1 January 2024. Additionally, the operator’s in-app reaction test will be activated daily from 25 December to 1 January between

Eevia Health Plc received a 434 KSEK / 39 KEUR sales order for a Bilberry extract product

Eevia Health Plc’s (”Eevia” or ”The Company”) has received a 39 KEUR sales order from French distributor Natural Ingredients, for Feno-Myrtillus 25 organic, an organically certified bilberry extract.Natural Ingredients is a French distributor company located near Angers, in the Loire Valley. Their specialty is natural and functional ingredients for the food supplement industry.  Natural Ingredients' reputation for delivering high-quality natural products aligns perfectly with Eevia Health's mission to promote health and well-being using sustainable arctic botanical extracts. The sales

BioStock: Medivir announce improved durable clinical benefit with fostrox

Medivir, whose ongoing rights issue ends today December 21, has announced that the lasting clinical benefit from the ongoing phase Ib/IIa study in advanced hepatocellular carcinoma continues to improve. According to the company, these data provide further support for accelerating the development program with fostrox and initiating a pivotal phase IIb study in second-line HCC in 2024.Read the article at biostock.se: https://www.biostock.se/en/2023/12/medivir-announce-improved-durable-clinical-benefit-with-fostrox/ This is a press release from BioStock - Connecting Innovation & Capital.

There are no items matching the current filter
There are no more items matching the current filter
Back to top